Unilateral cataract patients perform near and distance activities more easily

Article

Patients with unilateral cataract find it easier to perform near and distance activities than bilateral patients.

Patients with unilateral cataract find it easier to perform near and distance activities than bilateral patients, reveals a study in the Journal of Paediatric Ophthalmology and Strabismus.

Dr Caitriona Kirwan et al., Children's University Hospital, University College, Dublin, Ireland, conducted a retrospective chart review on 16 patients with a history of unilateral cataract and 22 patients with bilateral cataract. Each patient previously underwent surgery when aged 24 months of younger.

Patients aged 13 years or older were selected to partake in the study and educational performance was assessed. There was also a control group of 15 healthy participants with no visual complaints. All volunteers completed a questionnaire.

The bilateral cataract group found it harder to perform near and distance activities compared to the unilateral group. The bilateral group also had significantly lower vision-specific social functioning, role difficulties, mental health, and composite scores.

However, between the unilateral and bilateral groups there was no significant difference in ocular pain, vision-specific social functioning, role difficulties and dependency scores.

Both groups were comparable with regards to general vision scores, but the unilateral cataract group found it easier to perform near and distance activities and specific vision tasks.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.